Scopolamine butylbromide

CAS No. 149-64-4

Scopolamine butylbromide ( Butylscopolamine bromide; EINECS 205-744-1; Hyoscine butobromide )

Catalog No. M12073 CAS No. 149-64-4

Scopolamine butylbromide is a competitive antagonist of muscarinic acetylcholine receptor (mAChR) with an IC50 of 55.3 ± 4.3 nM.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 45 In Stock
100MG 51 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Scopolamine butylbromide
  • Note
    Research use only, not for human use.
  • Brief Description
    Scopolamine butylbromide is a competitive antagonist of muscarinic acetylcholine receptor (mAChR) with an IC50 of 55.3 ± 4.3 nM.
  • Description
    Scopolamine butylbromide is a competitive antagonist of muscarinic acetylcholine receptor (mAChR) with an IC50 of 55.3 ± 4.3 nM.
  • Synonyms
    Butylscopolamine bromide; EINECS 205-744-1; Hyoscine butobromide
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    mAChR
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    149-64-4
  • Formula Weight
    440.37
  • Molecular Formula
    C21H30NO4·Br
  • Purity
    >98%(HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    C[N@@+]1(CCCC)[C@@]2([H])[C@@]3([H])O[C@@]3([H])[C@]1([H])C[C@H](OC(C(C4=CC=CC=C4)CO)=O)C2.[Br-]
  • Chemical Name
    (1R,2R,4S,5S,7s,9s)-9-butyl-7-((3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Raufman JP, et al. Carcinogenesis. 2011 Sep;32(9):1396-402.
molnova catalog
related products
  • Catestatin

    Non-competitive nicotinic cholinergic antagonist; selectively inhibits nicotinic-stimulated catecholamine secretion from chromaffin cells and noradrenergic neurons (IC50 ~ 200 nM). Blocks nicotinic-induced cationic signaling (IC50 ~ 200 - 250 nM) and inhibits nicotinic-agonist induced desensitization of catecholamine release. Also stimulates mast cell release of histamine via a separate mechanism.

  • Darifenacin HBr

    Darifenacin is a selective muscarinic receptor antagonist.

  • PNU-282987 S enantio...

    PNU-282987 S enantiomer free base is an ?agonist of α7 nicotinic acetylcholine receptor (α7 nAChR).